A: Recombinant DNA technology is less effecti | vedclass

Name: Exam Paper Generator | JEE NEET Paper Generator | Vedclass
Brand: Vedclass
Rating: 5 (35 reviews)

Question

(D) The Assertion is incorrect because recombinant $DNA$ technology has been highly effective in producing therapeutic drugs,such as human insulin. Th

Vedclass · Accepted Answer

Both Assertion and Reason are incorrect.

Vedclass · Answer

(D) The Assertion is incorrect because recombinant $DNA$ technology has been highly effective in producing therapeutic drugs,such as human insulin. The Reason is also incorrect because recombinant therapeutics are designed to be identical to human proteins,thereby minimizing or preventing unwanted immunological responses that were common with non-human derived therapeutics. Therefore,both the Assertion and the Reason are incorrect.

$A$: Recombinant $DNA$ technology is less effective in therapeutic drug production.
$R$: Recombinant therapeutics induce unwanted immunological responses.

Similar Questions

Which protein production was successfully introduced in $E. coli$?

Genetically engineered human insulin is manufactured by the use of

.......... works on the principle of antigen-antibody interactions.

Which vaccine is produced using yeast?

Statement-$I$: In vitro fertilisation leading to a test tube baby is a part of biotechnology.
Statement-$II$: Developing a $\text{DNA}$ vaccine is a part of biotechnology.

Vedclass Test Series

Exam Paper Generator

Online Exam Module

$A$: Recombinant $DNA$ technology is less effective in therapeutic drug production.$R$: Recombinant therapeutics induce unwanted immunological responses.